An antioxidant that may help avoid damage to the liver caused by excessive drinking has been identified, which scientists say could pave the way for latest treatments to reverse steatosis or fatty deposits in the liver that can guide to cirrhosis and cancer. Researchers at the University of Alabama in Birmingham (UAB) found that the antioxidant, called mitochondria-targeted ubiquinone, or MitoQ, has been effective in interrupt and neutralising free radicals in alcoholics' livers before they can injure the organ.
For their study, published in the journal Hepatology, the researches introduce MitoQ to the mitochondria an organelle which change energy into forms that are usable by the cell of rats who were given alcohol each day for five to six weeks in an amount enough to mirror excessive intake in a human. Chronic alcoholics, those who drink to excess every day, skill a buildup of fat in the liver cells. When alcohol is metabolised in the liver, it creates free radicals that injure mitochondria in the liver cells and prevent them from using sufficient amounts of oxygen to create energy.
Rare diseases are likely to get more attention currently that an international consortium of patient advocacy groups and research funders has vowed to deliver 200 fresh therapies by 2020. For people with these diseases, such notice must seem long overdue. Drug companies now don’t have much incentive to expand drugs for diseases that affect fewer than 200,000 people, but almost 7,000 rare diseases exist disturbing a total of about 25 million Americans. Many are caused by mutations in a gene. The National Institutes of Health is opening a center in the fall to interpret research findings in genetics to usable therapies, the Associated Press reports.
The NIH previously has grant programs to spur research in rare diseases. The NIH's Therapeutics for Rare and Neglected Diseases plan has a pipeline of projects. Its pilot projects offer a glimpse into several of the diseases that, though rare, can nonetheless have incapacitating consequences. Schistosomiasis: Infection begins when a parasitic worm approved by freshwater snails penetrate the skin and lays eggs in blood vessels. First come rashes, then fever and chills, followed by liver and other organ injure over time. Researchers just decoded the genomes of two schistosomiasis-causing parasites, which may allow researchers to get ways to inhibit the parasites’ growth. About 200 million people worldwide have the disease, and 280,000 die from it every year.
Niemann-Pick Type C: In this condition, fatty deposits collect in the spleen, liver, lungs, bone marrow and brain. Type A, the most common, is fatal in infants. Type C can show early in life or in young adulthood; it causes brain damage and ultimately can change walking, swallowing, seeing and hearing. Only about 500 children in the world are recognized to have Type C. Researchers have found two genes that can give to Type C and Type D, but progress is slow. Hereditary inclusion body myopathy: Usually starting in young adulthood, the disease causes muscle wasting, foremost to severe disability in 10-20 years. A clinical trial in 2006 found mild benefits from intravenous immune globulin, fundamentally antibodies from blood plasma. A small gene therapy trial is happening, and stem cell therapy are being considered.
The risk of young people being admitted to hospital with alcohol associated liver disease has risen more than tenfold over five years. Researchers say the figures show anti drinking campaign are failing to reach teenagers. The most worrying enlarge in alcoholic cirrhosis, or late stage alcoholic liver disease, occur in those aged 20 to 29, who would have begun drinking in their untimely teens. The study by the Curtin University National Drug Research Institute also found an enlarged risk of young people developing alcoholic hepatitis, or young stage alcoholic liver disease.
While deaths due to alcoholic liver disease were falling overall, Associate Professor Tanya Chikritzhs of the organization said this was probable to have been due to advances in disease management. ''A lot of people see the number of deaths reduce and think that means things are improving. But just because there has been an development in treatment, that does not mean the occurrence is also going down.'' Professor Chikritzhs said better screening techniques for liver disease did not clarify such a marked enlarge, and that her research showed what several doctors and nurses had been suspect but until now did not have the research to support.
''Although people might be drinking the same volume of alcohol, there has been an enlarge in the consumption of products such as wine which have a higher alcohol content, with beer have an average of 4 per cent and red wine an average of 14 per cent.'' She distinct a heavy drinker as someone who drank more than 40 grams of alcohol per day, or four ordinary drinks, but said a like result could result from binge drinking two or three times per week. The chairman of the National Alliance for Action on Alcohol, Professor Mike Daube, said because alcoholic cirrhosis take years of heavy drinking to expand, people with the disease in their 20s were probable to have begun heavy drinking as young as 15.
A latest study by German researchers found that a difference in the PNPLA3 (adiponutrin) gene was connected with cirrhosis of the liver and elevated transaminase (liver enzyme) level in alcoholic Caucasians. The risk of cirrhosis in alcoholics in the genetic huge risk group might be as high as 25 to 50%. Full conclusion are published in the January 2011 subject of Hepatology, a magazine of the American Association for the Study of Liver Diseases.
Alcoholic liver disease variety from alcoholic fatty liver to alcohol persuade liver fibrosis and cirrhosis accounts for more than 50% all chronic liver disease in developed countries and was answerable for over 25,000 deaths in the U.S. alone in 2005. Studies have shown that while all deep drinkers display signs of hepatitis steatosis, only 10% to 35% of alcoholics expand hepatic inflammation, with up to 20% progressing to cirrhosis. Further medical proof suggests a link between PNPLA3 gene difference and liver fat content; specially the single nucleotide polymorphism rs738409 was report previously to be connected with advanced alcoholic liver disease in alcohol reliant individuals of European and Native American descent.
The German research side led by Jochen Hampe, MD, from Christian Albrechts Universität Kiel resolute the genotype and allele frequencies of PNPLA3 rs738409 in 1043 alcoholics with or without alcoholic liver damage and in 376 at risk drinkers from a people based cohort. Cirrhosis and steatosis was resolute by liver biopsy and standard diagnostic testing. Alanine aminotransferase and aspartate aminotransferase levels were recognized using custom clinical chemistry testing.
useful links : transport rankings
People living with chronic hepatitis C virus (HCV) disease and advanced liver disease who drink three or more cups of coffee per day have a 53 percent lower risk of liver disease series than non-coffee drinkers, according to a new study in print in the November issue of Hepatology. According to the paper, authored by Neal Freedman, PhD, MPH, of the National Cancer Institute and his colleagues, patients with hepatitis C–connected bridging fibrosis or cirrhosis who did not respond to standard treatment benefited from enlarged coffee intake.
This study included 766 participants enroll in the Hepatitis C Antiviral Long-Term Treatment beside Cirrhosis (HALT-C) trial who had hepatitis C–related bridging fibrosis or cirrhosis and failed to react to standard treatment with pegylated interferon and ribavirin. Upon entering the study, HALT-C volunteers were asked to statement their typical frequency of coffee intake and portion size over the past year. A alike question was asked for black and green tea intake.
Participants were seen every three months during the 3.8–year study period to assess clinical outcome that included: ascites, prognosis of chronic liver disease, death associated to liver disease, hepatic encephalopathy, hepatocellular carcinoma, spontaneous bacterial peritonitis, variceal hemorrhage and/or increase in fibrosis. Liver biopsies were also in use at 1.5 and 3.5 years to decide the progression of liver disease. Results showed that participant who drank three or more cups of coffee per day had a relative risk (RR) of 0.47 for attainment one of the clinical outcomes. An RR above 1.00 suggests an enlarge in the risk of disease progression, whereas an RR below 1.00 suggests a reduce in the risk of disease progression.
useful links : transport rankings
Curcumin, a chemical that give curry its zing, holds promise in prevent or treating liver damage from an advanced form of a condition known as fatty liver disease, new Saint Louis University research suggests. Curcurmin is contained in turmeric, a plant use by the Chinese to create traditional medicines for thousands of years. SLU’s current study highlights its possible in countering an increasingly common kind of fatty liver disease called non-alcoholic steatohepatitis (NASH). Linked to fatness and weight gain, NASH affects 3 to 4 percent of U.S. adults and can lead to a type of liver damage called liver fibrosis and maybe cirrhosis, liver cancer and death.
“My laboratory studies the molecular mechanism of liver fibrosis and is search for natural ways to avoid and treat this liver damage,” said Anping Chen, Ph.D., corresponding creator and director of research in the pathology department of Saint Louis University. “While research in an animal model and human clinical trials are wanted, our study suggests that curcumin may be an effective therapy to treat and avoid liver fibrosis, which is linked with non-alcoholic steatohepatitis (NASH).” High levels of blood leptin, glucose and insulin are commonly found in human patients with fatness and type 2 diabetes, which might give to NASH-associated liver fibrosis.
Chen’s most current work tested the effect of curcumin on the role of tall levels of leptin in causing liver fibrosis in vitro, or in a controlled lab setting. “Leptin plays a dangerous role in the development of liver fibrosis,” he said. High levels of leptin make active hepatic stellate cells, which are the cells that cause overproduction of the collagen protein, a main feature of liver fibrosis. The researchers found that among other actions, curcumin eliminated the property of leptin on activate hepatic stellate cells, which short circuited the development of liver damage. The findings were published in the September matter of Endocrinology.
useful links : transport rankings
Adults who have recently been diagnosed with diabetes may want to get their liver tested, as a new study has found that the metabolic illness can augment the chances of developing liver diseases, including cirrhosis and liver failure. Researchers from the University of Toronto tracked the medical records of 438,069 participants who had recently been diagnose with diabetes over the course of 13 years.
They then compare these records to a collection that did not have diabetes. They found that patients with the illness were more than twice as likely to expand liver disease. Dr Joel Ray, who led the study, said that patients with diabetes often carry excess fat, and that fatty deposits in the liver may explain this relationship.
"Those who have diabetes may not just have high blood sugars, but greater long-term insulin resistance and fatty load to the liver, which ultimately impacts on the integrity of the liver's cells," he said. Diabetes has previously been shown to pessimistically impact vision, kidney function and blood vessels, but this is the first study to show that the liver may also be affected.
useful links:
transport rankings
